Powerful, New Portraits Aim to Inspire People With Plaque Psoriasis or Psoriatic Arthritis to Show More of Their True Selves
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170622005635/en/
World-renowned for his portraiture, Schoeller has photographed a diverse
range of subjects including world leaders and celebrities, among others.
His portraits for the campaign feature notable names like
"As a storyteller, I want to bring out the true character of my subjects, and I believe the many faces of this campaign have inspiring stories to tell," said Schoeller. "I came to learn in the course of this project that it isn't always easy for people living with psoriasis or psoriatic arthritis to show who they truly are. I hope these portraits capture the authenticity of each individual, bring out their inner strength and outer beauty, and encourage others not to fear the spotlight."
No stranger to the spotlight,
"I'm proud to continue supporting the SHOW MORE OF YOU campaign to raise awareness of psoriatic disease and come together with others like me for this inspiring photo collection. We are all from different walks of life, with different careers and backgrounds, but we all share similar journeys that only someone who living with it can understand — and that is pretty special," said Torres. "I hope our stories empower others with psoriatic disease to follow their passions and show more of their true selves along the way."
The SHOW MORE OF YOU campaign, now in its second year, has evolved to not only raise awareness about psoriasis, but to also educate about psoriatic arthritis, as up to 30% of people with psoriasis may eventually develop psoriatic arthritis. Psoriasis is a common, chronic skin condition that affects nearly 7.5 million Americans, which results in increased skin cell growth that may appear on the skin as raised, sometimes red, patches covered with a silvery buildup of dead skin cells. More than 1 million Americans live with psoriatic arthritis — a potentially debilitating disease that involves significant pain to swelling in joints — and whose symptoms can impact a person's everyday life, including common day-to-day activities.
Otezla is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate. Otezla is also approved for the treatment of adults with active psoriatic arthritis. You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla. Otezla is associated with an increase in adverse reactions of depression, and some patients taking Otezla lost body weight. Please see Important Safety Information for Otezla below.
"As a dermatologist, I know all too well the toll psoriasis and
psoriatic arthritis can have on those with it," said
"Celgene is proud to have collaborated with
To learn more about the SHOW MORE OF YOU campaign and psoriatic disease, view Schoeller's portraits, and upload inspiring photos, visit ShowMoreOfYou.com.
Otezla® (apremilast) treats plaque psoriasis or psoriatic arthritis differently. Otezla is a convenient pill. It is not an injection, cream, shampoo, or biologic. For more information, talk to your doctor or visit www.otezla.com.
Otezla® (apremilast) is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.
Important Safety Information
You must not take Otezla® (apremilast) if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla is associated with an increase in adverse reactions of depression. In clinical studies, some patients reported depression and suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, suicidal thoughts, or suicidal behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.
Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.
Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.
Side effects of Otezla in psoriasis clinical studies were diarrhea, nausea, upper respiratory tract infection, tension headache, and headache.
Side effects of Otezla in psoriatic arthritis clinical studies were diarrhea, nausea, and headache.
These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.
Tell your doctor if you are pregnant, planning to become pregnant, or planning to breastfeed. Otezla has not been studied in pregnant women or in women who are breastfeeding.
You are encouraged to report negative side effects of prescription drugs
Visit www.fda.gov/medwatch, or call 1-800-332-1088.
Please click here for Full Prescribing Information.
This press release contains forward-looking statements, which are
generally statements that are not historical facts. Forward-looking
statements can be identified by the words "expects," "anticipates,"
"believes," "intends," "estimates," "plans," "will," "outlook" and
similar expressions. Forward-looking statements are based on
management's current plans, estimates, assumptions and projections, and
speak only as of the date they are made.
Patrick E. Flanigan III
Corporate Vice President, Investor Relations
Senior Director, Corporate Communications
News Provided by Acquire Media